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ORIGINAL ARTICLE
Molecular and Serological Intraocular Fluid Analysis of
Coxiella burnetii-seropositive Patients with Concurrent
Idiopathic Uveitis
L. E. Hermans, MS1,2, J. J. Oosterheert, MD, PhD3, L. M. Kampschreur, MD, PhD3,
J. Ossewaarde-van Norel, MD2, J. Dekkers, MS1,2, A. Rothova, MD, PhD2,4,
J. D. F. de Groot-Mijnes, MD, PhD1,2
1Department of Virology, 2Department of Ophthalmology, 3Department of Internal Medicine and Infectious
Diseases, 4Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands
ABSTRACT
Purpose: Previous studies have suggested a link between Q fever and uveitis. We determined whether Coxiella
burnetii causes intraocular infection in C. burnetii-seropositive patients with idiopathic uveitis.
Methods: From a retrospective observational case series, paired aqueous humor and serum samples from 10 C.
burnetii-seropositive patients with idiopathic uveitis were examined for intraocular antibody production by
using the Goldmann-Witmer coefficient and by polymerase chain reaction (PCR).
Results: Although intraocular IgG against C. burnetii was detected, no intraocular antibody production was
observed (low Goldmann Wittmer coefficients). All PCR results were negative.
Conclusions: Uveitis due to an intraocular infection with C. burnetii is unlikely.
Keywords: Aqueous humor analysis, Coxiella burnetii, infection, uveitis
Uveitis may be caused by intraocular infection or
systemic (autoimmune) disease,1,2 but remains idio-
pathic in approximately a quarter of cases. Intraocular
fluid analysis by both polymerase chain reaction
(PCR) and detection of intraocular antibody produc-
tion is of great value to distinguish infectious from
noninfectious uveitis.3 Moreover, it has led to the
discovery of new and putative infectious causes of
uveitis.4,5
Several cases have been described suggesting that
Coxiella burnetii, the causative agent of Q fever, may be
involved in the development of uveitis.6,7,8,9,10
In addition, one study reported the identification of
9 C. burnetii seropositive cases in a large cohort of
1520 idiopathic uveitis patients. While C. burnetii-
specific PCR analysis of anterior chamber fluid of
patients with a positive Q fever serology was
negative, the authors hypothesized that C. burnetii
caused uveitis in these cases in an antibody-mediated
manner.11,12 Determination of intraocular antibody
production against C. burnetii, which could confirm
this hypothesis, has not been reported yet. From mid
2007 till 2010 a Q fever epidemic occurred in the
Netherlands which was, with over 4000 reported
acute Q fever cases (which is an underestimation of
the real magnitude of the outbreak), unmatched
worldwide in size and duration.13 This event
allowed us to investigate the association between
Coxiella burnetii and uveitis more closely. Using PCR
and Goldmann-Witmer coefficient (GWC) analysis
to detect intraocular antibody production, we
set out to provide evidence for or against the
hypothesis that Coxiella burnetii is causally related to
uveitis.
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Patients were selected from a database of paired
aqueous humor and serum samples that were
collected for diagnostic purposes between 1 January
2008 and 31 December 2010 at the University Medical
Center Utrecht, a nationwide reference center for the
diagnosis of infectious uveitis. The intraocular fluid
samples had been stored at 80 C within 5 h of
collection prior to processing for laboratory analysis.
All samples had been analyzed by PCR and GWC
analysis for at least herpes simplex virus 1 and 2,
varicella zoster virus, and Treponema pallidum, and in
case of posterior uveitis also Toxoplasma gondii. We
hypothesized that putative cases of C. burnetii-
induced uveitis would be far more likely to occur in
those patients where no other infectious cause for the
uveitis has been found. Patients under the age of 18
years or with a laboratory-confirmed infectious
uveitis caused by cytomegalovirus, herpes simplex
virus types 1 and 2, varicella zoster virus, rubella
virus, or Toxoplasma gondii were excluded. HLA-B27-
positive patients and patients with sarcoidosis were
not excluded, as in these cases an infectious trigger
has been suggested.
To identify possible cases of uveitis and simulta-
neous C. burnetii infection, each patient’s municipality
of residence and year of first presentation with uveitis
was compared to epidemiological data on the inci-
dence of Q fever. Serological screening for Q fever was
performed in all those cases where patients presented
with uveitis while their municipality of residence was
affected by the epidemic. Intraocular fluids from all C.
burnetii-seropositive patients with idiopathic uveitis
were analyzed by PCR and intraocular antibody
production analysis. This study was performed
according to the tenets of the Declaration of Helsinki
and in agreement with the regulations of the institu-
tional review board of the Utrecht University Medical
Center (UMCU). All patients consented to the use of
their materials for research purposes.
Antibody Detection
Patients were screened for C. burnetii-specific IgG in
serum using the Panbio Coxiella burnetii (Q fever) IgG
ELISA (Panbio, Brisbane, Australia) according to the
instructions of the manufacturer. Intraocular antibody
production was determined by using the GWC
analysis essentially as described previously.3 C.
burnetii IgG titers were determined by analyzing 4
serial fourfold dilutions starting at 1:101 for serum
and 4 serial twofold dilutions starting at 1:50.5 for
intraocular fluid using the Panbio Coxiella burnetii (Q
fever) IgG ELISA. IgG titers were determined by
calculating the dilution at which the extrapolated
linear part of the ELISA curves crossed the cutoff
value. Total IgG concentrations were determined by
an in-house assay as described previously.3 The GWC
was calculated as follows ([specific IgG eye/total IgG
eye]:[specific IgG serum/total IgG serum]). Values
exceeding 3 are considered indicative of intraocular
antibody production.3
PCR Analysis
Taqman PCR analysis was performed as described
previously.3 Bacterial DNA was extracted from 12.5 mL
of ocular fluid using the MagNa Pure LC Total
Nucleic Acid isolation kit – large volume (Roche,
Almere, The Netherlands). To monitor the quality of
the extraction and the subsequent amplification
procedure a standard dose of phocine herpesvirus
type 1 (PhHV-1) was added to each sample as an
internal control prior to extraction.14 The DNA was
collected in a volume of 100 mL, and per PCR reaction
10 mL was added. The primers and probe for PhHV-1
DNA amplification were described previously.3 C.




TAMRA-30) as described in15 Taqman PCR was
performed on an ABI Prism 7900 HT sequence
detection system (Applied Biosystems, Foster City,
CA, USA). The analytical sensitivity of the assay was
determined to lie between 10 and 30 copies per
reaction. The analytical specificity is 100%. All
samples were analyzed in duplicate. None of the
samples were inhibited (Tilburg 2010).
RESULTS
A total of 773 adult patients suffering from presumed
noninfectious uveitis were included, 245 of which had
an elevated risk of Coxiella infection, as was deter-
mined by linking municipality to the epidemiological
data of the Dutch Q fever epidemic. Of these 245
patients, 85 had a uveitis of undefined etiology, 3 of
which had been found C. burnetii seropositive pre-
viously. Of the remaining 82 patients, sufficient serum
for C. burnetii antibody screening was available in 72
cases. Of these, 8 were seropositive, yielding 11 C.
burnetii-seropositive patients with idiopathic uveitis.
In 10 cases sufficient ocular fluid was available for
GWC determination. Intraocular IgG and thus the
GWC were negative in 8 patients. In 2 cases (1 and 9),
intraocular C. burnetii-specific IgG was positive,
but the GWC did not exceed 3, indicating that
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Coxiella-specific IgG was not produced locally, but had
leaked from the peripheral blood into the aqueous
chamber. PCR analysis was possible on the remain-
ders of 7 aqueous humor samples, but positive results
were not found. The clinical characteristics and
laboratory results of the examined C. burnetii-seropo-
sitive patients are listed in Table 1.
DISCUSSION
The present study is the first to examine intraocular C.
burnetii infection by analysis of intraocular fluid
samples using both GWC and PCR. Neither intrao-
cular antibody production nor C. burnetii DNA was
detected in seropositive patients identified from a
cohort of patients with idiopathic uveitis living in the
2007–2010 Q fever epidemic regions in the
Netherlands, suggesting that C. burnetii was not the
causative agent of the uveitis. Obviously, this study is
hampered by the relative low number of C. burnetii-
seropositive uveitis patients analyzed.
Assuming C. burnetii uveitis does exist, these
results could be explained by a low intraocular
bacterial load, concomitant with undetectable intrao-
cular antibody production. False-negative antibody
results could arise if only anti-phase I antibodies are
produced intraocularly, whereas the ELISA applied
here detects anti-phase II antibodies. However, this is
unlikely, as anti-phase II antibodies are present during
both the acute and chronic phases of the disease,
whereas anti-phase I antibodies are predominant in
chronic disease.16 Alternatively, C. burnetii uveitis
could result from an autoimmune or autoinflamma-
tory response triggered by the bacterial infection,
which is not identifiable by GWC or PCR.
On the other hand, Q fever-associated uveitis may
not exist at all. Six Coxiella-seropositive patients with
uveitis have been described in 5 medical case
reports,6,7,8,9,10 and an additional 9 cases were
recognized in a large survey.11,12 These 15 cases,
summarized in Table 2, show varying types of uveitis,
occurring either during episodes of Q fever or in
asymptomatic seropositive patients, as was the case in
our patient series. All but one of the previously
TABLE 2. Clinical characteristics of patients with concurrent uveitis and Coxiella burnetii seropositivity reported in literature.
Article Gender Age Country Q fever Uveitis characteristics Uveitis entities excluded
6 Female 33 France No Anterior unilateral Toxoplasmosis, rheumatism, TB
7 Male 22 France Yes Posterior bilateral Unspecified
Female 75 France No Posterior unilateral Unspecified
10 Male 44 Spain Yes Choroidal neovascularization Unspecified
9 Male 58 France Yes Anterior unilateral Syphilis, TB, sarcoidosis




11,12 Male 43 France Unknown Posterior unilateral Unspecified
Female 39 France Unknown Anterior unilateral Unspecified
Female 69 France Unknown Anterior unilateral Unspecified
Female 57 France Unknown Anterior bilateral Unspecified
Male 76 France Unknown Anterior bilateral Unspecified
Female 86 France Unknown Anterior unilateral Unspecified
Male 88 France Unknown Posterior unilateral Unspecified
Female 76 France Unknown Posterior unilateral Unspecified
Male 59 France Unknown Anterior unilateral Unspecified
TABLE 1. Clinical characteristics and laboratory results of Coxiella burnetii-seropositive patients with idiopathic uveitis.
Gender Age
Year of
sampling Clinical diagnosis Laterality Ocular IgG titer GWC PCR
1 Female 23 2010 Acute multifocal placoid pigment epitheliopathy Unilateral 1:387 1.96 Neg
2 Male 80 2010 Idiopathic panuveitis and fever Bilateral Neg Neg Neg
3 Female 39 2009 Idiopathic anterior uveitis Bilateral Neg Neg Neg
4 Female 69 2009 Anterior uveitis and sarcoidosis Bilateral Neg Neg Neg
5 Female 51 2009 Nodular scleritis and aortitis Unilateral Neg Neg nd
6 Male 43 2009 Idiopathic chorioretinitis Unilateral Neg Neg Neg
7 Male 60 2009 Idiopathic panuveitis Bilateral Neg Neg Neg
8 Male 49 2009 Idiopathic panuveitis Unilateral Neg Neg Neg
9 Female 48 2010 Panuveitis and papillitis – 1:51 2.86 nd
10 Male 66 2009 Idiopathic neuroretinitis Unilateral Neg Neg Neg
GWC, Goldmann-Witmer coefficient; PCR, polymerase chain reaction; nd, not determined.
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described cases concern patients from France, a
country where Q fever is endemic to many rural
regions. Also, in the described cases, it is often unclear
if other possible causes of uveitis were ruled out. The
combined data, therefore, support the hypothesis that
coexistence of Q fever and uveitis is merely a chance
finding.
In conclusion, although it cannot be ruled out that
C. burnetii is associated with uveitis, the current
combined data suggest that intraocular infection
with C. burnetii is an unlikely cause of uveitis.
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